| 1 |
Todorova VB, Baxan N, Delahaye M, Harding SE, Rankin SM. Drug-based mobilisation of mesenchymal stem/stromal cells improves cardiac function post myocardial infarction. Dis Model Mech 2023;16:dmm049630. [PMID: 36263604 DOI: 10.1242/dmm.049630] [Reference Citation Analysis]
|
| 2 |
Karimian M, Nouri N, Ghasemi LV, Mohammadi AH, Behjati M. Administration of stem cells against cardiovascular diseases with a focus on molecular mechanisms: Current knowledge and prospects. Tissue Cell 2023;81:102030. [PMID: 36709696 DOI: 10.1016/j.tice.2023.102030] [Reference Citation Analysis]
|
| 3 |
Ning Y, Huang P, Chen G, Xiong Y, Gong Z, Wu C, Xu J, Jiang W, Li X, Tang R, Zhang L, Hu M, Xu J, Xu J, Qian H, Jin C, Yang Y. Atorvastatin-pretreated mesenchymal stem cell-derived extracellular vesicles promote cardiac repair after myocardial infarction via shifting macrophage polarization by targeting microRNA-139-3p/Stat1 pathway. BMC Med 2023;21:96. [PMID: 36927608 DOI: 10.1186/s12916-023-02778-x] [Reference Citation Analysis]
|
| 4 |
Kishino Y, Fukuda K. Unlocking the Pragmatic Potential of Regenerative Therapies in Heart Failure with Next-Generation Treatments. Biomedicines 2023;11:915. [DOI: 10.3390/biomedicines11030915] [Reference Citation Analysis]
|
| 5 |
Lang CI, Dahmen A, Vasudevan P, Lemcke H, Gäbel R, Öner A, Ince H, David R, Wolfien M. Cardiac cell therapies for the treatment of acute myocardial infarction in mice: systematic review and meta-analysis. Cytotherapy 2023:S1465-3249(23)00032-4. [PMID: 36890093 DOI: 10.1016/j.jcyt.2023.01.013] [Reference Citation Analysis]
|
| 6 |
Kalou Y, Al-Khani AM, Haider KH. Bone Marrow Mesenchymal Stem Cells for Heart Failure Treatment: A Systematic Review and Meta-Analysis. Heart Lung Circ 2023:S1443-9506(23)00068-9. [PMID: 36872163 DOI: 10.1016/j.hlc.2023.01.012] [Reference Citation Analysis]
|
| 7 |
Blanco-Blázquez V, Báez-Díaz C, Sánchez-Margallo FM, González-Bueno I, Martín H, Blázquez R, Casado JG, Usón A, Solares J, Palacios I, Steendam R, Crisóstomo V. Intracoronary Administration of Microencapsulated HGF in a Reperfused Myocardial Infarction Swine Model. J Cardiovasc Dev Dis 2023;10. [PMID: 36826582 DOI: 10.3390/jcdd10020086] [Reference Citation Analysis]
|
| 8 |
Duda GN, Geissler S, Checa S, Tsitsilonis S, Petersen A, Schmidt-Bleek K. The decisive early phase of bone regeneration. Nat Rev Rheumatol 2023;19:78-95. [PMID: 36624263 DOI: 10.1038/s41584-022-00887-0] [Reference Citation Analysis]
|
| 9 |
Zhou P, Yu SN, Zhang HF, Wang YL, Tao P, Tan YZ, Wang HJ. c-kit(+)VEGFR-2(+) Mesenchymal Stem Cells Differentiate into Cardiovascular Cells and Repair Infarcted Myocardium after Transplantation. Stem Cell Rev Rep 2023;19:230-47. [PMID: 35962935 DOI: 10.1007/s12015-022-10430-z] [Reference Citation Analysis]
|
| 10 |
Tsujimoto H, Osafune K. Current status and future directions of clinical applications using iPS cells-focus on Japan. FEBS J 2022;289:7274-91. [PMID: 34407307 DOI: 10.1111/febs.16162] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Ha GH, Kim EJ, Park JS, Kim JE, Nam H, Yeon JY, Lee SH, Lee K, Kim CK, Joo KM. JAK2/STAT3 pathway mediates neuroprotective and pro-angiogenic treatment effects of adult human neural stem cells in middle cerebral artery occlusion stroke animal models. Aging (Albany NY) 2022;14:8944-69. [PMID: 36446389 DOI: 10.18632/aging.204410] [Reference Citation Analysis]
|
| 12 |
Saffari TM, Saffari S, Vyas KS, Mardini S, Shin AY. Role of adipose tissue grafting and adipose-derived stem cells in peripheral nerve surgery. Neural Regen Res 2022;17:2179-84. [PMID: 35259826 DOI: 10.4103/1673-5374.336870] [Reference Citation Analysis]
|
| 13 |
Sharma V, Manhas A, Gupta S, Dikshit M, Jagavelu K, Verma RS. Fabrication, characterization and in vivo assessment of cardiogel loaded chitosan patch for myocardial regeneration. International Journal of Biological Macromolecules 2022. [DOI: 10.1016/j.ijbiomac.2022.10.079] [Reference Citation Analysis]
|
| 14 |
Mahapatra S, Sharma MVR, Brownson B, Gallicano VE, Gallicano GI. Cardiac inducing colonies halt fibroblast activation and induce cardiac/endothelial cells to move and expand via paracrine signaling. Mol Biol Cell 2022;33:ar96. [PMID: 35653297 DOI: 10.1091/mbc.E22-02-0032] [Reference Citation Analysis]
|
| 15 |
Xia HF, Lai WQ, Chen GH, Li Y, Xie QH, Jia YL, Chen G, Zhao YF. A histological study of vascular wall resident stem cells in venous malformations. Cell Tissue Res 2022. [PMID: 35916917 DOI: 10.1007/s00441-022-03672-3] [Reference Citation Analysis]
|
| 16 |
Abu-el-rub E, Zegallai HM, Aloud BM, Sekaran S, Miller DW. Magnetic Nanoparticles for Imaging, Diagnosis, and Drug-Delivery Applications. Bionanotechnology: Next-Generation Therapeutic Tools 2022. [DOI: 10.2174/9789815051278122010007] [Reference Citation Analysis]
|
| 17 |
Mahmud S, Alam S, Emon NU, Boby UH, Kamruzzaman, Ahmed F, Monjur-al-hossain A, Tahamina A, Rudra S, Ajrin M. Opportunities and challenges in stem cell therapy in cardiovascular diseases: Position standing in 2022. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.06.017] [Reference Citation Analysis]
|
| 18 |
Gara E, Ong S, Winkler J, Zlabinger K, Lukovic D, Merkely B, Emmert MY, Wolint P, Hoerstrup SP, Gyöngyösi M, Wu JC, Pavo N. Cell-Based HIF1α Gene Therapy Reduces Myocardial Scar and Enhances Angiopoietic Proteome, Transcriptomic and miRNA Expression in Experimental Chronic Left Ventricular Dysfunction. Front Bioeng Biotechnol 2022;10:767985. [DOI: 10.3389/fbioe.2022.767985] [Reference Citation Analysis]
|
| 19 |
Bonanni M, Rehak L, Massaro G, Benedetto D, Matteucci A, Russo G, Esperto F, Federici M, Mauriello A, Sangiorgi GM. Autologous Immune Cell-Based Regenerative Therapies to Treat Vasculogenic Erectile Dysfunction: Is the Immuno-Centric Revolution Ready for the Prime Time? Biomedicines 2022;10:1091. [DOI: 10.3390/biomedicines10051091] [Reference Citation Analysis]
|
| 20 |
Sarre C, Contreras-Lopez R, Nernpermpisooth N, Barrere C, Bahraoui S, Terraza C, Tejedor G, Vincent A, Luz-Crawford P, Kongpol K, Kumphune S, Piot C, Nargeot J, Jorgensen C, Djouad F, Barrere-Lemaire S. PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia-reperfusion injury. Stem Cell Res Ther 2022;13:167. [PMID: 35461240 DOI: 10.1186/s13287-022-02840-0] [Reference Citation Analysis]
|
| 21 |
Poomani MS, Mariappan I, Perumal R, Regurajan R, Muthan K, Subramanian V. Mesenchymal Stem Cell (MSCs) Therapy for Ischemic Heart Disease: A Promising Frontier. Global Heart 2022;17:19. [DOI: 10.5334/gh.1098] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 22 |
Kang X, Chen Y, Xin X, Liu M, Ma Y, Ren Y, Ji J, Yu Q, Qu L, Wang S, Liu G, Xiang C, Yang L. Human Amniotic Epithelial Cells and Their Derived Exosomes Protect Against Cisplatin-Induced Acute Kidney Injury Without Compromising Its Antitumor Activity in Mice. Front Cell Dev Biol 2022;9:752053. [DOI: 10.3389/fcell.2021.752053] [Reference Citation Analysis]
|
| 23 |
Neef K, Drey F, Lepperhof V, Wahlers T, Hescheler J, Choi Y, Šarić T. Co-transplantation of Mesenchymal Stromal Cells and Induced Pluripotent Stem Cell-Derived Cardiomyocytes Improves Cardiac Function After Myocardial Damage. Front Cardiovasc Med 2022;8. [DOI: 10.3389/fcvm.2021.794690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 24 |
Joy Thomas J, John J, Ushakumary MG. Stem cell-driven tissue regeneration as treatment for COVID-19. Stem Cells and COVID-19 2022. [DOI: 10.1016/b978-0-323-89972-7.00002-7] [Reference Citation Analysis]
|
| 25 |
Yang W, Li HY, Wu YF, Mi RJ, Liu WZ, Shen X, Lu YX, Jiang YH, Ma MJ, Shen HY. ac4C acetylation of RUNX2 catalyzed by NAT10 spurs osteogenesis of BMSCs and prevents ovariectomy-induced bone loss. Mol Ther Nucleic Acids 2021;26:135-47. [PMID: 34513300 DOI: 10.1016/j.omtn.2021.06.022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 26 |
Li X, Zhang Y, Ren X, Wang Y, Chen D, Li Q, Huo M, Shi J. Ischemic Microenvironment-Responsive Therapeutics for Cardiovascular Diseases. Adv Mater 2021;33:e2105348. [PMID: 34623714 DOI: 10.1002/adma.202105348] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 27 |
Mahlke MA, Cheng K, Li B, Chaudhari S, Navara CS, McCarrey JR. Validation of baboon pluripotent cells as a model for translational stem cell research. Stem Cell Res 2021;57:102598. [PMID: 34864219 DOI: 10.1016/j.scr.2021.102598] [Reference Citation Analysis]
|
| 28 |
Nath AV, Ajit S, Sekar AJ, P R AK, Muthusamy S. MicroRNA-200c/429 mediated regulation of Zeb1 augments N-Cadherin in mouse cardiac mesenchymal cells. Cell Biol Int 2021. [PMID: 34747544 DOI: 10.1002/cbin.11724] [Reference Citation Analysis]
|
| 29 |
Liu H, Cai A, Li Z, Ma H, Fan L, Ma J, Zhao D. MicroRNA-204 Attenuates Oxidative Damage in Cardiac Stem Cell Through Regulation of Bone Marrow Stromal Cell (BMSC) Adipogenic and Osteogenic Differentiation. j biomater tissue eng 2021;11:2203-9. [DOI: 10.1166/jbt.2021.2802] [Reference Citation Analysis]
|
| 30 |
Gong H, Wang T, Xu Q. Resident stem cells in the heart. Medical Review 2021;1:10-3. [DOI: 10.1515/mr-2021-0003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 31 |
Infante A, Rodríguez CI. Cell and Cell-Free Therapies to Counteract Human Premature and Physiological Aging: MSCs Come to Light. J Pers Med 2021;11:1043. [PMID: 34683184 DOI: 10.3390/jpm11101043] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 32 |
Ravaud C, Ved N, Jackson DG, Vieira JM, Riley PR. Lymphatic Clearance of Immune Cells in Cardiovascular Disease. Cells 2021;10:2594. [PMID: 34685572 DOI: 10.3390/cells10102594] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 33 |
Sharma V, Dash SK, Govarthanan K, Gahtori R, Negi N, Barani M, Tomar R, Chakraborty S, Mathapati S, Bishi DK, Negi P, Dua K, Singh SK, Gundamaraju R, Dey A, Ruokolainen J, Thakur VK, Kesari KK, Jha NK, Gupta PK, Ojha S. Recent Advances in Cardiac Tissue Engineering for the Management of Myocardium Infarction. Cells 2021;10:2538. [PMID: 34685518 DOI: 10.3390/cells10102538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 34 |
Ivankovic I, Déan-Ben XL, Haas H, Kimm MA, Wildgruber M, Razansky D. Volumetric Optoacoustic Tomography Differentiates Myocardial Remodelling. Mol Imaging Biol 2020;22:1235-43. [PMID: 32394284 DOI: 10.1007/s11307-020-01498-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 35 |
Mamazhakypov A, Sommer N, Assmus B, Tello K, Schermuly RT, Kosanovic D, Sarybaev AS, Weissmann N, Pak O. Novel Therapeutic Targets for the Treatment of Right Ventricular Remodeling: Insights from the Pulmonary Artery Banding Model. Int J Environ Res Public Health 2021;18:8297. [PMID: 34444046 DOI: 10.3390/ijerph18168297] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 36 |
Al-Sowayan BS, Al-Shareeda AT. Stem cells and the pursuit of youth, a tale of limitless possibilities and commercial fraud. World J Biol Chem 2021; 12(4): 52-56 [PMID: 34354805 DOI: 10.4331/wjbc.v12.i4.52] [Reference Citation Analysis]
|
| 37 |
Shouman S, Zaher A, Abdelhameed A, Elshaboury S, Sakr S, Fouda BE, Mohamed H, El-Badri N. Cardiac Progenitor Cells. Adv Exp Med Biol 2021;1312:51-73. [PMID: 33159305 DOI: 10.1007/5584_2020_594] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 38 |
Huang K, Ozpinar EW, Su T, Tang J, Shen D, Qiao L, Hu S, Li Z, Liang H, Mathews K, Scharf V, Freytes DO, Cheng K. An off-the-shelf artificial cardiac patch improves cardiac repair after myocardial infarction in rats and pigs. Sci Transl Med 2020;12:eaat9683. [PMID: 32269164 DOI: 10.1126/scitranslmed.aat9683] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 39.0] [Reference Citation Analysis]
|
| 39 |
Deppen JN, Ginn SC, Kim NH, Wang L, Voll RJ, Liang SH, Goodman MM, Oshinski JN, Levit RD. A Swine Hind Limb Ischemia Model Useful for Testing Peripheral Artery Disease Therapeutics. J Cardiovasc Transl Res 2021. [PMID: 34050499 DOI: 10.1007/s12265-021-10134-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 40 |
Madonna R, Guarnieri S, Kovácsházi C, Görbe A, Giricz Z, Geng YJ, Mariggiò MA, Ferdinandy P, De Caterina R. Telomerase/myocardin expressing mesenchymal cells induce survival and cardiovascular markers in cardiac stromal cells undergoing ischaemia/reperfusion. J Cell Mol Med 2021;25:5381-90. [PMID: 33949765 DOI: 10.1111/jcmm.16549] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 41 |
Li J, Hu S, Zhu D, Huang K, Mei X, López de Juan Abad B, Cheng K. All Roads Lead to Rome (the Heart): Cell Retention and Outcomes From Various Delivery Routes of Cell Therapy Products to the Heart. J Am Heart Assoc 2021;10:e020402. [PMID: 33821664 DOI: 10.1161/JAHA.120.020402] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
|
| 42 |
Nong Y, Guo Y, Tomlin A, Zhu X, Wysoczynski M, Li Q, Bolli R. Echocardiography-guided percutaneous left ventricular intracavitary injection as a cell delivery approach in infarcted mice. Mol Cell Biochem 2021;476:2135-48. [PMID: 33547546 DOI: 10.1007/s11010-021-04077-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 43 |
Klaourakis K, Vieira JM, Riley PR. The evolving cardiac lymphatic vasculature in development, repair and regeneration. Nat Rev Cardiol 2021;18:368-79. [PMID: 33462421 DOI: 10.1038/s41569-020-00489-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
|
| 44 |
Galow AM, Goldammer T, Hoeflich A. Xenogeneic and Stem Cell-Based Therapy for Cardiovascular Diseases: Genetic Engineering of Porcine Cells and Their Applications in Heart Regeneration. Int J Mol Sci 2020;21:E9686. [PMID: 33353186 DOI: 10.3390/ijms21249686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 45 |
Charles CJ, Li RR, Yeung T, Mazlan SMI, Lai RC, de Kleijn DPV, Lim SK, Richards AM. Systemic Mesenchymal Stem Cell-Derived Exosomes Reduce Myocardial Infarct Size: Characterization With MRI in a Porcine Model. Front Cardiovasc Med 2020;7:601990. [PMID: 33304934 DOI: 10.3389/fcvm.2020.601990] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 46 |
Gao L, Zhang H, Cui J, Pei L, Huang S, Mao Y, Liu Z, Wei K, Zhu H. Single-cell transcriptomics of cardiac progenitors reveals functional subpopulations and their cooperative crosstalk in cardiac repair. Protein Cell 2021;12:152-7. [PMID: 33159668 DOI: 10.1007/s13238-020-00788-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 47 |
Faris P, Negri S, Perna A, Rosti V, Guerra G, Moccia F. Therapeutic Potential of Endothelial Colony-Forming Cells in Ischemic Disease: Strategies to Improve their Regenerative Efficacy. Int J Mol Sci 2020;21:E7406. [PMID: 33036489 DOI: 10.3390/ijms21197406] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 48 |
Su T, Huang K, Mathews KG, Scharf VF, Hu S, Li Z, Frame BN, Cores J, Dinh PU, Daniele MA, Ligler FS, Cheng K. Cardiac Stromal Cell Patch Integrated with Engineered Microvessels Improves Recovery from Myocardial Infarction in Rats and Pigs. ACS Biomater Sci Eng 2020;6:6309-20. [PMID: 33449654 DOI: 10.1021/acsbiomaterials.0c00942] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
|
| 49 |
Winkler J, Lukovic D, Mester-Tonczar J, Zlabinger K, Gugerell A, Pavo N, Jakab A, Szankai Z, Traxler D, Müller C, Spannbauer A, Riesenhuber M, Hašimbegović E, Dawkins J, Zimmermann M, Ankersmit HJ, Marbán E, Gyöngyösi M. Quantitative Hybrid Cardiac [18F]FDG-PET-MRI Images for Assessment of Cardiac Repair by Preconditioned Cardiosphere-Derived Cells. Mol Ther Methods Clin Dev 2020;18:354-66. [PMID: 32671138 DOI: 10.1016/j.omtm.2020.06.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 50 |
Turner D, Rieger AC, Balkan W, Hare JM. Clinical-based Cell Therapies for Heart Disease-Current and Future State. Rambam Maimonides Med J. 2020;11. [PMID: 32374254 DOI: 10.5041/rmmj.10401] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
|
| 51 |
Nong Y, Guo Y, Tomlin A, Zhu X, Wysoczynski M, Li Q, Bolli R. Echocardiography-guided percutaneous left ventricular intracavitary injection as a cell delivery approach in infarcted mice.. [DOI: 10.1101/2020.03.31.018358] [Reference Citation Analysis]
|
| 52 |
Vagnozzi RJ, Sargent MA, Molkentin JD. Cardiac Cell Therapy Rejuvenates the Infarcted Rodent Heart via Direct Injection but Not by Vascular Infusion. Circulation 2020;141:1037-9. [PMID: 32202933 DOI: 10.1161/CIRCULATIONAHA.119.044686] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 53 |
Lou X, Zhao M, Fan C, Fast VG, Valarmathi MT, Zhu W, Zhang J. N-cadherin overexpression enhances the reparative potency of human-induced pluripotent stem cell-derived cardiac myocytes in infarcted mouse hearts. Cardiovasc Res 2020;116:671-85. [PMID: 31350544 DOI: 10.1093/cvr/cvz179] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
|
| 54 |
Kore RA, Henson JC, Hamzah RN, Griffin RJ, Tackett AJ, Ding Z, Mehta JL. Molecular events in MSC exosome mediated cytoprotection in cardiomyocytes. Sci Rep 2019;9:19276. [PMID: 31848380 DOI: 10.1038/s41598-019-55694-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 55 |
Yan G, Yuan Y, He M, Gong R, Lei H, Zhou H, Wang W, Du W, Ma T, Liu S, Xu Z, Gao M, Yu M, Bian Y, Pang P, Li X, Yu S, Yang F, Cai B, Yang L. m6A Methylation of Precursor-miR-320/RUNX2 Controls Osteogenic Potential of Bone Marrow-Derived Mesenchymal Stem Cells. Mol Ther Nucleic Acids 2020;19:421-36. [PMID: 31896070 DOI: 10.1016/j.omtn.2019.12.001] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 13.5] [Reference Citation Analysis]
|
| 56 |
Murphy JF, Mayourian J, Stillitano F, Munawar S, Broughton KM, Agullo-Pascual E, Sussman MA, Hajjar RJ, Costa KD, Turnbull IC. Adult human cardiac stem cell supplementation effectively increases contractile function and maturation in human engineered cardiac tissues. Stem Cell Res Ther 2019;10:373. [PMID: 31801634 DOI: 10.1186/s13287-019-1486-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 57 |
Huang P, Wang L, Li Q, Xu J, Xu J, Xiong Y, Chen G, Qian H, Jin C, Yu Y, Liu J, Qian L, Yang Y. Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance. Stem Cell Res Ther 2019;10:300. [PMID: 31601262 DOI: 10.1186/s13287-019-1353-3] [Cited by in Crossref: 55] [Cited by in F6Publishing: 64] [Article Influence: 13.8] [Reference Citation Analysis]
|
| 58 |
Cohen JA, Almodovar MC. Dilated cardiomyopathy in children: moving beyond traditional pharmacologic therapy. Curr Opin Cardiol 2020;35:52-7. [PMID: 31574005 DOI: 10.1097/HCO.0000000000000692] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 59 |
Lodola F, Rosti V, Tullii G, Desii A, Tapella L, Catarsi P, Lim D, Moccia F, Antognazza MR. Conjugated polymers optically regulate the fate of endothelial colony-forming cells. Sci Adv 2019;5:eaav4620. [PMID: 31598549 DOI: 10.1126/sciadv.aav4620] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
|
| 60 |
Mei T, Le W, Cao H, Wang Z, Tang W, Liu Z, Shi D. Cell Therapy and 3D Regenerative Tissue to Remodel Heart Failure. Nano LIFE 2019;09:1941001. [DOI: 10.1142/s1793984419410010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 61 |
Crisostomo V, Baez C, Abad JL, Sanchez B, Alvarez V, Rosado R, Gómez-Mauricio G, Gheysens O, Blanco-Blazquez V, Blazquez R, Torán JL, Casado JG, Aguilar S, Janssens S, Sánchez-Margallo FM, Rodriguez-Borlado L, Bernad A, Palacios I. Dose-dependent improvement of cardiac function in a swine model of acute myocardial infarction after intracoronary administration of allogeneic heart-derived cells. Stem Cell Res Ther 2019;10:152. [PMID: 31151405 DOI: 10.1186/s13287-019-1237-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
|
| 62 |
Yan W, Abu-El-Rub E, Saravanan S, Kirshenbaum LA, Arora RC, Dhingra S. Inflammation in myocardial injury: mesenchymal stem cells as potential immunomodulators. Am J Physiol Heart Circ Physiol 2019;317:H213-25. [PMID: 31125258 DOI: 10.1152/ajpheart.00065.2019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 63 |
Michels da Silva D, Langer H, Graf T. Inflammatory and Molecular Pathways in Heart Failure—Ischemia, HFpEF and Transthyretin Cardiac Amyloidosis. IJMS 2019;20:2322. [DOI: 10.3390/ijms20092322] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 7.5] [Reference Citation Analysis]
|
| 64 |
Hernandez Schulman I, M. Hare J. Mesenchymal Stromal Cells as a Therapeutic Intervention. Stromal Cells - Structure, Function, and Therapeutic Implications 2019. [DOI: 10.5772/intechopen.78586] [Reference Citation Analysis]
|
| 65 |
Bakalorz K, Los LD, Wiecheć E. Introduction and Historic Perspective. Stem Cells and Biomaterials for Regenerative Medicine 2019. [DOI: 10.1016/b978-0-12-812258-7.00001-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 66 |
Willadsen M, Chaise M, Yarovoy I, Zhang AQ, Parashurama N. Engineering molecular imaging strategies for regenerative medicine. Bioeng Transl Med 2018;3:232-55. [PMID: 30377663 DOI: 10.1002/btm2.10114] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
|
| 67 |
Belostotskaya GB, Nerubatskaya IV, Galagudza MM. Two mechanisms of cardiac stem cell-mediated cardiomyogenesis in the adult mammalian heart include formation of colonies and cell-in-cell structures. Oncotarget 2018;9:34159-75. [PMID: 30344929 DOI: 10.18632/oncotarget.26148] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
